Exploring iDose® TR: The Future of Glaucoma Management thumbnail

Exploring iDose® TR: The Future of Glaucoma Management

Published en
1 min read


iDose® TR is a game-changing innovation in the treatment of glaucoma, providing a long-term and efficient method for managing intraocular pressure (IOP). Unlike traditional eye drops that need to be applied every day, iDose® TR is a small, implantable device engineered to release a controlled dispensation of treatment directly into the eye over an longer period. This groundbreaking approach reduces the burden of constant dosing, significantly improving patient adherence and overall treatment effectiveness.

At Eye Center South, we are honored to introduce iDose® TR as part of our holistic glaucoma care. The device is placed during a minimally invasive procedure, focused on your comfort and ease. Once in place, it ensures a steady release of glaucoma medication, helping to maintain stable IOP levels and protect your vision. Patients who struggle with the challenges of daily eye drop regimens can benefit greatly from this state-of-the-art treatment.



Visit for more info At Eye Center South